{
    "2014-03-25": [
        "PFE Xalkori (Crizotinib) treatment met the main goal in Phase III trial of untreated patients of lung cancer significantly prolonging PFS",
        "Pfizer Inc. PFE XALKORIÂ® Beats Chemo For Previously Untreated Patients In Phase 3 Study",
        "GTAT Daily Chart Most recent stock chart and technical analysis."
    ]
}